Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionNissay Asset Management Corp /japan/ /adv
Latest Disclosed Ownership348,686 shares
Latest Disclosed Value $ 48,596,368
Nissay Asset Management Corp /japan/ /adv reports 2.13% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Nissay Asset Management Corp /japan/ /adv filed a 13F-HR form disclosing ownership of 348,686 shares of Gilead Sciences, Inc. (CH:GILD) valued at $48,596,368 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 341,422 shares of Gilead Sciences, Inc.. This represents a change in shares of 2.13% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 348,686 7,264 2.13 48,596 15.96 0.2575
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM 375558103 341,422 14,446 4.42 41,906 15.46 0.2180
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 326,976 5,043 1.57 36,294 1.69 0.2004
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 321,933 10,412 3.34 35,693 2.25 0.2089
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 311,521 27,278 9.60 34,906 30.49 0.2269
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 284,243 14,009 5.18 26,750 18.07 0.1631
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 270,234 21,211 8.52 22,656 32.61 0.1435
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 249,023 27,046 12.18 17,085 5.08 0.1131
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 221,977 49,153 28.44 16,260 16.14 0.1127
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 172,824 14,049 8.85 14,000 17.67 0.1126
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 158,775 9,911 6.66 11,899 3.71 0.1055
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 148,864 -709 -0.47 11,473 -7.56 0.0990
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 149,573 -4,801 -3.11 12,410 -6.36 0.1109
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 154,374 1,347 0.88 13,253 40.39 0.1267
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 153,027 5,617 3.81 9,440 3.61 0.0991
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 147,410 606 0.41 9,111 4.40 0.0907
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 146,804 2,748 1.91 8,727 -16.57 0.0760
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 144,056 3,182 2.26 10,460 6.30 0.0801
2021-11-10 2021-09-30 13F GILEAD SCIENCES COM 375558103 140,874 -3,718 -2.57 9,840 -1.18 0.0834
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 144,592 2,860 2.02 9,957 8.70 0.0874
2021-05-11 2021-03-31 13F GILEAD SCIENCES COM 375558103 141,732 -4,015 -2.75 9,160 7.88 0.0903
2021-02-08 2020-12-31 13F GILEAD SCIENCES COM 375558103 145,747 -7,060 -4.62 8,491 -12.07 0.1277
2020-10-20 2020-09-30 13F GILEAD SCIENCES COM 375558103 152,807 -21,444 -12.31 9,656 -27.98 0.1631
2020-07-27 2020-06-30 13F GILEAD SCIENCES COM 375558103 174,251 8,208 4.94 13,407 8.01 0.2602
2020-05-05 2020-03-31 13F GILEAD SCIENCES COM 375558103 166,043 1,049 0.64 12,413 15.78 0.3160
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM 375558103 164,994 -5,903 -3.45 10,721 -1.02 0.2383
2019-11-14 2019-09-30 13F GILEAD SCIENCES COM 375558103 170,897 5,396 3.26 10,831 -3.13 0.2680
2019-08-07 2019-06-30 13F GILEAD SCIENCES COM 375558103 165,501 -6,515 -3.79 11,181 -0.02 0.2826
2019-05-03 2019-03-31 13F GILEAD SCIENCES COM 375558103 172,016 -7,965 -4.43 11,183 -0.67 0.2955
2019-02-06 2018-12-31 13F GILEAD SCIENCES COM 375558103 179,981 -1,634 -0.90 11,258 -19.71 0.3431
2018-10-30 2018-09-30 13F GILEAD SCIENCES COM 375558103 181,615 -30,076 -14.21 14,022 -6.50 0.3773
2018-08-08 2018-06-30 13F GILEAD SCIENCES COM 375558103 211,691 -34,131 -13.88 14,996 -19.08 0.4387
2018-05-14 2018-03-31 13F GILEAD SCIENCES COM 375558103 245,822 -22,283 -8.31 18,533 -3.50 0.5791
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 268,105 268,105 19,206 0.5849
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.